Comparison of in-hospital mortality between the two groups
| Survivors (n=33) | Non-survivors (n=8) | P value | |
| Prior to ECMO | |||
| Peak lactate (mmol/L) | 7.2 (3.68–10.40) | 6.8 (3.68–13.73) | 0.428 |
| VIS | 25 (10–40) | 30 (12.25–45.5) | 0.856 |
| EF (%) | 29 (30–50.5) | 29 (14–39.8) | 0.065 |
| LV (cm) | 3.55 (3.25–4.28) | 3.80 (3.55–4.15) | 0.468 |
| During ECMO | |||
| Peak CRE (μmol/L) | 61 (44.63–73.5) | 147.75 (93–207.75) | 0.000* |
| Peak ALT (U/L) | 71 (43.5–631.5) | 682 (182.25–1361) | 0.021* |
| Peak BNP (pg/mL) | 6517 (2262–23 096) | 5853.50 (3902.75–22 539.25) | 0.818 |
| Peak CKMB (ng/mL) | 71.94 (43.29–175) | 277.50 (188.25–321.75) | 0.001* |
| Peak cTNI (ng/mL) | 1.80 (0.52–8.16) | 3.91 (0.13–40) | 0.742 |
| VIS at the 24th hour | 9 (3.5–23) | 28.5 (15.2–47.5) | 0.003* |
Data are presented as mean (IQR).
*P＜0.05.
ALT, alanine transaminase; BNP, brain natriuretic peptide; CKMB, creatine kinase isoenzyme MB; CRE, creatinine; cTNI, cardiac troponin I; ECMO, extracorporeal membrane oxygenation; EF, ejection fraction; LV, left ventricular; VIS, vasoactive-inotropic score.